Heron Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HRTX Nasdaq 2836 www.herontx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Heron Therapeutics, Inc.

Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... - Aug 10th, 2026 3:01 pm
Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Aug 10th, 2026 9:05 am
Heron Therapeutics Q2 Earnings Call Highlights - Aug 10th, 2026 8:04 am
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Aug 10th, 2026 7:10 am
BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates - Aug 5th, 2026 7:00 am
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026 - Jul 27th, 2026 6:30 am
New Strong Sell Stocks for July 15th - Jul 15th, 2026 4:24 am
Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision - Jul 11th, 2026 6:16 pm
Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? - Jun 30th, 2026 6:58 am
Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? - Jun 2nd, 2026 9:04 pm
Sector Update: Healthcare Stocks Softer Late Afternoon - Jun 2nd, 2026 1:45 pm
U.S. District Court Issues Decision Regarding CINVANTI® Patents - Jun 2nd, 2026 6:12 am
Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright? - May 19th, 2026 5:08 am
Heron Therapeutics Inc (HRTX) Q1 2026 Earnings Call Highlights: Resilient Growth Amidst Challenges - May 12th, 2026 1:02 am
Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 11th, 2026 2:51 pm
Heron Therapeutics Q1 Earnings Call Highlights - May 11th, 2026 9:07 am
Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline - May 11th, 2026 9:03 am